Cargando...

Tolerating Factor VIII: Recent Progress

Development of neutralizing antibodies against biotherapeutic agents administered to prevent or treat various clinical conditions is a longstanding and growing problem faced by patients, medical providers and pharmaceutical companies. The hemophilia A community has deep experience with attempting to...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Immunol
Main Authors: Lacroix-Desmazes, Sebastien, Voorberg, Jan, Lillicrap, David, Scott, David W., Pratt, Kathleen P.
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2020
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6965068/
https://ncbi.nlm.nih.gov/pubmed/31998296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.02991
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!